Keevin R Davis, MD | |
3328 Princeton Road, Hamilton, OH 45011 | |
(513) 887-9400 | |
(513) 887-7512 |
Full Name | Keevin R Davis |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 3328 Princeton Road, Hamilton, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568480176 | NPI | - | NPPES |
0811536 | Medicaid | OH | |
H073500 | Other | OH | MEDICARE PTAN |
000000590417 | Other | OH | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 35046494 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Keevin R Davis, MD 3460 Davis Ln, Cincinnati, OH 45237-2402 Ph: (513) 482-9291 | Keevin R Davis, MD 3328 Princeton Road, Hamilton, OH 45011 Ph: (513) 887-9400 |
News Archive
MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $1.9 million contract with a Global pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.
Lukas Kopacki, home from college after the coronavirus pandemic closed his campus, was feeling lousy for days with headaches, sore throat and difficulty breathing through his nose. But he worried that a trip to a doctor's office might make him sicker.
China PharmaHub Corp., a pharmaceutical HUB between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, announced today that it has entered into a Merger Agreement with World Wide Relics, Inc.. The merger is expected to close in August 2010.
Angiogenesis, the formation of new blood vessels, is essential for tumor growth. A new study reported in The American Journal of Pathology describes a vascular stabilization biomarker that can visualize blood vessel activity, thus optimizing the timing of anticancer therapies including anti-angiogenics.
Minimally invasive robot-assisted surgery, which has become the main choice for surgically removing cancerous prostate glands during recent years, is as safe as open surgery for Medicare patients over age 65.
› Verified 5 days ago